RxDoctor Payments Data

Marc Weiss, MD

Psychiatry · Boca Raton, FLNPI 1467665091

Payments from drug & device makers

$753in general payments, 2019–2025

Across 34 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$465
  • Johnson & Johnson$136
  • E.r. Squibb & Sons, L.L.C.$58
  • Teva Pharmaceuticals USA, Inc.$38
  • Indivior Inc.$36
  • Otsuka America Pharmaceutical, Inc.$20

What the payments were for

  • Food & beverage$753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$753 in reported general payments places this provider in the 55th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$105,123
Medicare patients
275
Services billed
1,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate14$39,110
DepakoteDivalproex Sodium13$9,419
Aripiprazole74$9,033
SeroquelQuetiapine Fumarate13$8,580
Chlorpromazine Hcl46$5,560
Ziprasidone Hcl68$4,207
Haloperidol137$3,952
Clozapine55$2,541
Divalproex Sodium154$2,276
Fluphenazine Hcl32$1,579
Paliperidone ErPaliperidone16$1,569
Haloperidol Decanoate43$1,355
Bupropion XlBupropion Hcl140$1,293
Risperidone215$1,272
Divalproex Sodium ErDivalproex Sodium54$1,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$136$39,11014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →